Application of Rapid, Blood Culture-Free Diagnostics in the Emergency Department: Improving the Signal to Noise Ratio
Mitchell J. Cohen, M.D.
Director of Surgery
Denver Health & the University of Colorado School of Medicine, Denver, CO
This symposium offers expert guidance on the application of T2MR® technology in the Emergency Department setting. Currently in FDA-clinical trials, the T2Bacteria® Panel identifies bloodstream infection pathogens commonly isolated from patients throughout the hospital, and most often presenting in the Emergency Department. Learn how T2Bacteria may help improve your patient triage, case management and admission processes.
Managing Sepsis in the Golden Hour: Controlling Costs and Improving Patient Care through Diagnostic Testing
Jonathan D. Edwards, Pharm.D., BCPS (AQ-ID), BCGP
Huntsville Hospital, Huntsville, AL
Thomas Kirn, MD, PHD
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
The goal of this symposium is to provide a forum for peer-to-peer learning on the proven impact of T2MR technology. This session reviews the positive patient care impact and economic benefits realized by using the only FDA-cleared, direct-from-whole-blood assay for the identification of sepsis-causing pathogens, while also discussing products in development that may have a similar impact on healthcare.